Stock Track | MannKind Plummets 16% Intraday After Q4 Earnings Miss Expectations

Stock Track

Feb 27

MannKind Corporation (MNKD) shares plummeted approximately 16% during intraday trading on Thursday, following the release of the company's fourth-quarter financial results.

The biopharmaceutical company reported a net loss of $0.05 per share for the quarter ended December 31, 2025, which fell short of analyst expectations. According to an earnings summary, the mean expectation of eight analysts was for earnings of one cent per share, representing a significant miss. The company's adjusted loss of 5 cents per share also contrasted with earnings of 3 cents per share in the same quarter last year.

While MannKind's quarterly revenue of $112 million exceeded the analyst estimate of $97.6 million, the earnings disappointment appears to have driven the sharp sell-off. The company reported a Q4 operating loss of $7.687 million and a net loss of $15.948 million, contributing to negative investor sentiment despite revenue growth.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1156346913"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156346913\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156346913?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 02:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156346913","market":"hk","top_or_hot":-1,"title":"Stock Track | MannKind Plummets 16% Intraday After Q4 Earnings Miss Expectations","media":"Stock Track","content":"<p>MannKind Corporation (MNKD) shares plummeted approximately 16% during intraday trading on Thursday, following the release of the company's fourth-quarter financial results.</p><p>The biopharmaceutical company reported a net loss of $0.05 per share for the quarter ended December 31, 2025, which fell short of analyst expectations. According to an earnings summary, the mean expectation of eight analysts was for earnings of one cent per share, representing a significant miss. The company's adjusted loss of 5 cents per share also contrasted with earnings of 3 cents per share in the same quarter last year.</p><p>While MannKind's quarterly revenue of $112 million exceeded the analyst estimate of $97.6 million, the earnings disappointment appears to have driven the sharp sell-off. The company reported a Q4 operating loss of $7.687 million and a net loss of $15.948 million, contributing to negative investor sentiment despite revenue growth.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | MannKind Plummets 16% Intraday After Q4 Earnings Miss Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | MannKind Plummets 16% Intraday After Q4 Earnings Miss Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-27 02:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MannKind Corporation (MNKD) shares plummeted approximately 16% during intraday trading on Thursday, following the release of the company's fourth-quarter financial results.</p><p>The biopharmaceutical company reported a net loss of $0.05 per share for the quarter ended December 31, 2025, which fell short of analyst expectations. According to an earnings summary, the mean expectation of eight analysts was for earnings of one cent per share, representing a significant miss. The company's adjusted loss of 5 cents per share also contrasted with earnings of 3 cents per share in the same quarter last year.</p><p>While MannKind's quarterly revenue of $112 million exceeded the analyst estimate of $97.6 million, the earnings disappointment appears to have driven the sharp sell-off. The company reported a Q4 operating loss of $7.687 million and a net loss of $15.948 million, contributing to negative investor sentiment despite revenue growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MNKD","symbol_name":"曼恩凯德生物医疗","start_time":0,"source_url":"","article_id":"1156346913","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156346913","pubTimestamp":1772131976,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"MannKind Corporation (MNKD) shares plummeted approximately 16% during intraday trading on Thursday, following the release of the company's fourth-quarter financial results.The biopharmaceutical...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MNKD":"曼恩凯德生物医疗"},"translate_title":"个股追踪|Q4财报不及预期MannKind盘中暴跌16%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MNKD":1},"content_text":"MannKind Corporation (MNKD) shares plummeted approximately 16% during intraday trading on Thursday, following the release of the company's fourth-quarter financial results.The biopharmaceutical company reported a net loss of $0.05 per share for the quarter ended December 31, 2025, which fell short of analyst expectations. According to an earnings summary, the mean expectation of eight analysts was for earnings of one cent per share, representing a significant miss. The company's adjusted loss of 5 cents per share also contrasted with earnings of 3 cents per share in the same quarter last year.While MannKind's quarterly revenue of $112 million exceeded the analyst estimate of $97.6 million, the earnings disappointment appears to have driven the sharp sell-off. The company reported a Q4 operating loss of $7.687 million and a net loss of $15.948 million, contributing to negative investor sentiment despite revenue growth.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}